Latest News and Press Releases
Want to stay updated on the latest news?
-
PT. HUENEME, CA--(Marketwire - July 12, 2010) - Stellar Biotechnologies, Inc. (PINKSHEETS: SBOTF) (TSX-V: KLH) (www.stellarbiotechnologies.com) is pleased to announce that eminent biochemist,...
-
PORT HUENEME, CA--(Marketwire - June 29, 2010) - Stellar Biotechnologies, Inc. (PINKSHEETS: SBOTF) (TSX-V: KLH) has appointed John S. Sundsmo, Ph.D., VP - Research & Intellectual Property...
-
PORT HUENEME, CA--(Marketwire - June 22, 2010) - A Stellar Biotechnologies, Inc. (PINKSHEETS: SBOTF) (TSX-V: KLH) tem o prazer de anunciar que lançou um novo website dedicado aos seus clientes...
-
PORT HUENEME, CALIFORNIA--(Marketwire - June 22, 2010) - Stellar Biotechnologies, Inc. (PINKSHEETS: SBOTF) (TSX-V: KLH) se complace en anunciar el lanzamiento de su nuevo portal diseñado para...
-
PORT HUENEME, CA--(Marketwire - June 22, 2010) - Stellar Biotechnologies, Inc. (PINKSHEETS: SBOTF) (TSX-V: KLH) is pleased to announce that it has released its new customer and investor-friendly...
-
PORT HUENEME, CA--(Marketwire - June 10, 2010) - Stellar Biotechnologies, Inc. (TSX-V: KLH) (PINKSHEETS: SBOTF) will initiate preclinical testing of its immunogenic agent, Stellar KLH/NeoA,...
-
PORT HUENEME, CA--(Marketwire - June 2, 2010) - Stellar Biotechnologies, Inc. (TSX-V: KLH) ("Stellar") is pleased to announce that its long-term customer, Neovacs SA - Paris (Paris Alternext: ALNEV),...
-
VANCOUVER, BC--(Marketwire - May 12, 2010) - Stellar Biotechnologies, Inc. (TSX-V: KLH) has appointed Dr. Andrew Saxon, a world-renowned expert in human cellular and molecular immunology, Andrew...
-
VANCOUVER, BC--(Marketwire - April 29, 2010) - Stellar Biotechnologies, Inc. (TSX-V: KLH) has appointed eminent scientist Daniel E. Morse, Ph. D. as Director and Executive VP: Science &...
-
VANCOUVER, BC--(Marketwire - April 20, 2010) - CAG Capital (now Stellar Biotechnologies, Inc.) (TSX-V: KLH) announces acquisition of Stellar Biotechnologies --...